Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition
Clinical trial NCT04941196 · COMPLETED
Trial details
- NCT number
- NCT04941196
- Sponsor
- University of Karachi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-16
- Primary completion
- 2020-10-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.